You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 685 A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Novel single-agent immunotherapies
685 A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020204042
Dec 202097017
Jan 202190031
Feb 202144028
Mar 202174018
Apr 202144021
May 202116022
Jun 20210012
Jul 20210021
Aug 20210025
Sep 20210034
Oct 202132030
Nov 202144035
Dec 20212005
Jan 202236010
Feb 202232014
Mar 202258031
Apr 202276014
May 202284018
Jun 20224409
Jul 20223405
Aug 202240010
Sep 202224011
Oct 20222605
Nov 202226012
Dec 20222603
Jan 202352010
Feb 20233602
Mar 20233806
Apr 202326013
May 20231603
Jun 2023804
Jul 20232206
Aug 20231001
Sep 20231805
Oct 20232402
Nov 20232906
Dec 20233001
Jan 20243805
Feb 20243203
Mar 202414013
Apr 202414011
May 20242402
Jun 20242806
Jul 20242204
Aug 20241606
Sep 20241805
Oct 202428011
Nov 20241407
Dec 2024807
Jan 202524012
Feb 20258011
Mar 20250011
Apr 2025009
May 2025006
Jun 2025006
Total17680677